Amna Bamaqa, N S Labeeb, Eman M El-Gendy, Hani M Ibrahim, Mohamed Farsi, Hossam Magdy Balaha, Mahmoud Badawy, Mostafa A Elhosseini
{"title":"A Dual-Feature Framework for Enhanced Diagnosis of Myeloproliferative Neoplasm Subtypes Using Artificial Intelligence.","authors":"Amna Bamaqa, N S Labeeb, Eman M El-Gendy, Hani M Ibrahim, Mohamed Farsi, Hossam Magdy Balaha, Mahmoud Badawy, Mostafa A Elhosseini","doi":"10.3390/bioengineering12060623","DOIUrl":null,"url":null,"abstract":"<p><p>Myeloproliferative neoplasms, particularly the Philadelphia chromosome-negative (Ph-negative) subtypes such as essential thrombocythemia, polycythemia vera, and primary myelofibrosis, present diagnostic challenges due to overlapping morphological features and clinical heterogeneity. Traditional diagnostic approaches, including imaging and histopathological analysis, are often limited by interobserver variability, delayed diagnosis, and subjective interpretations. To address these limitations, we propose a novel framework that integrates handcrafted and automatic feature extraction techniques for improved classification of Ph-negative myeloproliferative neoplasms. Handcrafted features capture interpretable morphological and textural characteristics. In contrast, automatic features utilize deep learning models to identify complex patterns in histopathological images. The extracted features were used to train machine learning models, with hyperparameter optimization performed using Optuna. Our framework achieved high performance across multiple metrics, including precision, recall, F1 score, accuracy, specificity, and weighted average. The concatenated probabilities, which combine both feature types, demonstrated the highest mean weighted average of 0.9969, surpassing the individual performances of handcrafted (0.9765) and embedded features (0.9686). Statistical analysis confirmed the robustness and reliability of the results. However, challenges remain in assuming normal distributions for certain feature types. This study highlights the potential of combining domain-specific knowledge with data-driven approaches to enhance diagnostic accuracy and support clinical decision-making.</p>","PeriodicalId":8874,"journal":{"name":"Bioengineering","volume":"12 6","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2025-06-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12189774/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioengineering","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3390/bioengineering12060623","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Myeloproliferative neoplasms, particularly the Philadelphia chromosome-negative (Ph-negative) subtypes such as essential thrombocythemia, polycythemia vera, and primary myelofibrosis, present diagnostic challenges due to overlapping morphological features and clinical heterogeneity. Traditional diagnostic approaches, including imaging and histopathological analysis, are often limited by interobserver variability, delayed diagnosis, and subjective interpretations. To address these limitations, we propose a novel framework that integrates handcrafted and automatic feature extraction techniques for improved classification of Ph-negative myeloproliferative neoplasms. Handcrafted features capture interpretable morphological and textural characteristics. In contrast, automatic features utilize deep learning models to identify complex patterns in histopathological images. The extracted features were used to train machine learning models, with hyperparameter optimization performed using Optuna. Our framework achieved high performance across multiple metrics, including precision, recall, F1 score, accuracy, specificity, and weighted average. The concatenated probabilities, which combine both feature types, demonstrated the highest mean weighted average of 0.9969, surpassing the individual performances of handcrafted (0.9765) and embedded features (0.9686). Statistical analysis confirmed the robustness and reliability of the results. However, challenges remain in assuming normal distributions for certain feature types. This study highlights the potential of combining domain-specific knowledge with data-driven approaches to enhance diagnostic accuracy and support clinical decision-making.
期刊介绍:
Aims
Bioengineering (ISSN 2306-5354) provides an advanced forum for the science and technology of bioengineering. It publishes original research papers, comprehensive reviews, communications and case reports. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. All aspects of bioengineering are welcomed from theoretical concepts to education and applications. There is no restriction on the length of the papers. The full experimental details must be provided so that the results can be reproduced. There are, in addition, four key features of this Journal:
● We are introducing a new concept in scientific and technical publications “The Translational Case Report in Bioengineering”. It is a descriptive explanatory analysis of a transformative or translational event. Understanding that the goal of bioengineering scholarship is to advance towards a transformative or clinical solution to an identified transformative/clinical need, the translational case report is used to explore causation in order to find underlying principles that may guide other similar transformative/translational undertakings.
● Manuscripts regarding research proposals and research ideas will be particularly welcomed.
● Electronic files and software regarding the full details of the calculation and experimental procedure, if unable to be published in a normal way, can be deposited as supplementary material.
● We also accept manuscripts communicating to a broader audience with regard to research projects financed with public funds.
Scope
● Bionics and biological cybernetics: implantology; bio–abio interfaces
● Bioelectronics: wearable electronics; implantable electronics; “more than Moore” electronics; bioelectronics devices
● Bioprocess and biosystems engineering and applications: bioprocess design; biocatalysis; bioseparation and bioreactors; bioinformatics; bioenergy; etc.
● Biomolecular, cellular and tissue engineering and applications: tissue engineering; chromosome engineering; embryo engineering; cellular, molecular and synthetic biology; metabolic engineering; bio-nanotechnology; micro/nano technologies; genetic engineering; transgenic technology
● Biomedical engineering and applications: biomechatronics; biomedical electronics; biomechanics; biomaterials; biomimetics; biomedical diagnostics; biomedical therapy; biomedical devices; sensors and circuits; biomedical imaging and medical information systems; implants and regenerative medicine; neurotechnology; clinical engineering; rehabilitation engineering
● Biochemical engineering and applications: metabolic pathway engineering; modeling and simulation
● Translational bioengineering